Heerma Peter: insider trades.
Heerma Peter reported 14 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($17.9M), across 1 company.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Heerma Peter
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Officer · EVP, CHIEF COMMERCIAL OFFICER | 14 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. | M | 8,282 | $22.4 | 125,348 | Form 4 |
| 2026-09-17 | Travere Therapeutics, Inc. | S | 8,282 | $65.07 | 117,066 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 55,000 | $15.46 | 272,066 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 17,717 | $26.88 | 289,783 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 93,604 | $63.25 | 196,179 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | S | 79,113 | $63.65 | 117,066 | Form 4 |
| 2026-09-16 | Travere Therapeutics, Inc. | M | 100,000 | $11.25 | 217,066 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 1,431 | $65.31 | 117,066 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 1,400 | $63.65 | 118,497 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 27,421 | $62.59 | 119,897 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 71,938 | $62.05 | 147,318 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 36,526 | $8.93 | 219,256 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 1,381 | $22.4 | 182,730 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 39,283 | $26.88 | 181,349 | Form 4 |
Questions
What stock did Heerma Peter buy or sell?
Heerma Peter reported 14 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($17.9M), across 1 company.
Is Heerma Peter the same person as other filers with this name?
This page covers SEC CIK 1789617 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/heerma-peter-1789617.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.